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608Objectives: It is not clear whether clinically silent tricuspid valve regurgitation should be addressed at the time
of mitral valve repair for severe mitral regurgitation due to leaflet prolapse. We examined the clinical and
echocardiographic outcomes of patients with tricuspid regurgitation who underwent only mitral valve repair.
Methods: We retrospectively analyzed records of patients undergoing mitral valve repair for isolated mitral
valve prolapsewho had coexistent tricuspid valve regurgitation during an 11-year period at our institution. Echo-
cardiographic data were compared preoperatively, intraoperatively, and postoperatively at less than 1, 1 to 3, 3 to
5, and more than 5 years.
Results: In 699 patients who underwent mitral valve repair for severe mitral regurgitation, mean age was
60.4 years and 459 (66%) were male. At the time of mitral valve repair, tricuspid valve regurgitation was grade
3 or more in 115 (16%) patients and less than grade 3 in 584 (84%) patients. After mitral valve repair, overall
grade of tricuspid valve regurgitation decreased significantly within the first year (P ¼ .01). In patients with
grade 3 regurgitation or more, the grade decreased at dismissal and until the third year (P< .001). Female
sex, preoperative atrial fibrillation, and diabetes mellitus were independent risk factors for increased tricuspid
valve regurgitation with time; preoperative regurgitation of grade 3 or more independently predicted decreased
grade with time. Only 1 patient required tricuspid reoperation 4.5 years after mitral repair.
Conclusions: Clinically silent nonsevere tricuspid valve regurgitation in patients with degenerative mitral valve
disease is unlikely to progress after mitral valve repair. Tricuspid valve surgery is rarely necessary for most pa-
tients undergoing repair of isolated mitral valve prolapse. (J Thorac Cardiovasc Surg 2011;142:608-13)Functional tricuspid valve regurgitation (TR) is common in
patients with left-sided cardiac valve disease.1,2 Although
early reports suggested that TR may resolve after the
diseased mitral valve (MV) is replaced,1 subsequent data
have shown that severe TR may develop late after MV sur-
gery for rheumatic or ischemic disease, even in the absence
of significant residual mitral stenosis, regurgitation, or other
causes of left-sided heart failure.2-4 Severe symptomatic
residual TR compromises long-term outcomes after MV
surgery and is associated with increased early and midterm
morbidity andmortality, despite adequateMV correction.2-6
However, previous studies have focused mainly on patients
with ischemic, rheumatic, or mixed heart valve disease
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The Journal of Thoracic and Cardiovascular Surgcannot be readily extended to patients undergoing isolated
repair for degenerative MV disease. Specifically, few data
have addressed the progression of clinically silent,
functional TR and the need for reoperation after repair of
mitral leaflet prolapse. It is therefore unclear whether the
tricuspid valve (TV) should be addressed at the time of
isolated MV repair. We analyzed the clinical and
echocardiographic outcomes of patients with clinically
silent functional TR in whom only MV repair was
performed.PATIENTS AND METHODS
We searched our prospective patient database for the records of patients
who underwent MV repair for isolated MV prolapse and who had coexis-
tent, clinically silent, functional TR between January 1, 1995, and January
1, 2006, at Mayo Clinic, Rochester, Minnesota. The study was reviewed
and approved by the Mayo Clinic Institutional Review Board. The need
for individual patient consent was waived because relevant identifiers
were not included in the dataset. We excluded patients who declined in-
volvement in clinical research, who had concomitant coronary artery by-
pass grafting surgery, or who had other concomitant cardiac procedures
other than closure of a patent foramen ovale. Also excluded were patients
with an initial diagnosis of MV regurgitation (MR) caused by congenital,
rheumatic, or ischemic heart disease or cardiomyopathy and those with
endocarditis causing leaflet defects or subvalvular abscess. Patients with
primary pulmonary disease, significant right ventricular dysfunction, or
structural TV abnormalities (including stenosis) were also not included.
Fifty-two patients who had TR associated with right heart failureery c September 2011
TABLE 1. Patient baseline characteristics
Characteristic Value* (N ¼ 699)
Age, y 60.4 (13.7)
Male sex 459 (65.7)
Preoperative EF,% 65.12 (7.57)
Preoperative TR grade
1 233 (33.3)
2 351 (50.2)
3–4 115 (16.5)
Preoperative AF 122 (17.5)
Preoperative dilatation
RA 203 (29.0)
RV 31 (4.4)
NYHA class
I 199 (28.5)
II 258 (36.9)
III 220 (31.5)
IV 22 (3.1)
EF, Ejection fraction; TR, tricuspid valve regurgitation; AF, atrial fibrillation; RA,
right atrium; RV, right ventricle; NYHA, New York Heart Association. *Values are
no. (%) or mean (standard deviation).
Abbreviations and Acronyms
MR ¼ mitral valve regurgitation
MV ¼ mitral valve
SD ¼ standard deviation
TR ¼ tricuspid valve regurgitation
TV ¼ tricuspid valve
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interval, and these patients were analyzed in a separate report.
All patients underwent MV repair for severe MR owing to leaflet pro-
lapse. The techniques used during MV repair have been described else-
where.11 The most common method of surgical correction for posterior
leaflet prolapsewas triangular resection and suture reconstruction of the in-
volved scallop, supplemented by a standard-length (63-mm) flexible poste-
rior annuloplasty band. For repair of anterior leaflet prolapse, artificial
polytetrafluoroethylene neochordae were used. Chordal shortening,
chordal transfer, commissural annuloplasty, and leaflet plication were
used infrequently.
TR in each patient was quantified echocardiographically as follows:
grade 1, trivial; grade 2, mild; grade 3, moderate; and grade 4, severe.
TR data were analyzed during the following time periods: preoperatively,
intraoperatively, and postoperatively at less than 1 year, 1 to 3 years, 3 to
5 years, and more than 5 years. Clinical follow-up data were collected
through routine postoperative surveys (at 1, 3, 5, 10, 15, and 20 years)
and contact with referring cardiologists.
STATISTICAL ANALYSIS
Descriptive statistics for categorical variables are re-
ported as frequency and percentage, and continuous vari-
ables are given as mean (standard deviation [SD]). The
Kaplan–Meier method was used to estimate 5-year and
10-year survival. Changes in TR from preoperative values
to those at dismissal and postoperatively at less than 1
year, 1 to 3 years, 3 to 5 years, and more than 5 years of
follow-up were analyzed on the basis of the subgroup of pa-
tients whose data were available at the corresponding time
periods. Changes were compared using paired t tests or the
Wilcoxon rank sum test as appropriate. Predictors of echo-
cardiographic change in TR after 5 years of follow-up were
identified by fitting linear regression models. The multivar-
iate model considered univariately significant variables
(P<.05) with model selection using the stepwise method
(backward and forward techniques were similar). Cox
regression models were used to determine univariate and
multivariate predictors of late mortality. All statistical tests
were 2-sided, with the a level set at .05 for statistical
significance.
RESULTS
A total of 699 patients undergoing isolated MV repair
met the inclusion criteria for the study. The mean (SD)
age was 60.4 (13.7) years, and 459 (65.7%) were male. Pre-
operatively, most patients (457, 65.4%) had New York
Heart Association class I–II symptoms, whereas 242The Journal of Thoracic and Ca(34.6%) had class III–IV symptoms. The baseline charac-
teristics of the patients are shown in Table 1. MV leaflet pro-
lapse was posterior in 377 patients (53.9%), whereas
280 (40.1%) had bileaflet prolapse and 42 (6%) had iso-
lated anterior leaflet prolapse. No patients had right heart
failure, and although all patients had some degree of coex-
istent functional TR, none was deemed by the surgeon to re-
quire TV intervention at the time of MV repair. According
to preoperative echocardiography, 115 (16%) patients had
grade 3 or higher TR, and the remaining 584 (84%) had
less than grade 3 TR.Intraoperative TR Evaluation
In the 115 patients with grade 3 or higher TR preopera-
tively, we compared TR grade at different time points re-
lated to surgery: preoperative, intraoperative prebypass,
intraoperative postbypass, and predismissal (Figure 1).
Mean intraoperative TR grades while patients were under
general anesthesia (both prebypass and postbypass) were
significantly lower than both preoperative and predismissal
levels (P<.001 for both).Change in TR During Follow-up
The mean (SD) duration of follow-up for the group was
5.5 (3) years. TR grade was compared at different time pe-
riods after surgery (Figure 2, A). The mean preoperative TR
grade was 1.84 (0.71). Compared with the preoperative
value, overall mean TR grade decreased significantly within
the first year (n ¼ 248; 1.72 [0.79]; P ¼ .01) and increased
slightly only after 5 years of follow-up (n ¼ 108; 2.11
[0.92]; P¼ .03). There was no significant change from pre-
operative levels at the other time periods examined.rdiovascular Surgery c Volume 142, Number 3 609
FIGURE 1. Mean grade of tricuspid valve regurgitation (TR) at different
points relative to surgery for patients with preoperative grade 3–4 TR
(n ¼ 115). Preop, Preoperative; Predis, predismissal. *P< .001 (paired
t test or Wilcoxon rank sum test).
FIGURE 2. Mean grade of tricuspid valve regurgitation (TR) at different
time points. A, All patients. B, All patients separated by preoperative grade
of TR: grade 1–2, black bars; grade 3–4, white bars. Preop, Preoperative;
Predis, predismissal. *P<.001; yP<.01 (paired t test or Wilcoxon rank
sum test).
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sessed after stratification of the study population into 2
groups: those with preoperative TR less than moderate
(n ¼ 581) and those with moderate or greater TR
(n ¼ 115) (Figure 2, B). In patients with less than moderate
preoperative TR (mean grade, 1.6 [0.49]), mean TR grade
remained stable and increased only slightly after 5 years
(mean, 2.0 [0.86]; P<.01). Conversely, in thosewith at least
moderate preoperative TR, mean TR grade decreased sig-
nificantly from preoperative values after MV repair
(P<.001 at dismissal,<1 year, and 1–3 years). Mean TR
grade was also decreased after 3 years of follow-up, but
the changes were not statistically significant (P ¼ .18 after
3 years; P ¼ .33 after 5 years). Only 1 reoperation (TV re-
pair) for severe symptomatic TRwas necessary 4.5 years af-
ter the initial MV operation. The patient had moderate
preoperative TR at the time of MV repair, and significant
right ventricular dysfunction developed shortly after sur-
gery. The distributions of functional TR and recurrent MR
with time are shown in Appendix Table 1.Predictors of Change in TR
Univariate analysis was performed and multivariate
models were constructed to determine the influence of pre-
operative and intraoperative variables on change in TR after
MV repair (Table 2). Female sex (P ¼ .009), preoperative
atrial fibrillation (P<.001), and comorbid diabetes mellitusTABLE 2. Predictors of change in TR grade*
Univariate Multivariate
Parameter P value
Parameter
estimate P value
Parameter
estimate
Female sex .02 0.405 .009 0.441
Age .37 0.006
Hypertension .08 0.312
Diabetes mellitus .02 1.181 .02 1.112
Previous AF <.001 0.642 <.001 0.628
Preoperative echocardiography
RA dilatation .03 0.577
RV dilatation .18 0.510
EF .10 0.017
LVMI .67 0.001
LAVI .56 0.005
PAP .71 0.003
TR velocity .64 0.100
Preoperative TR (grade 3-4) .03 0.525 .008 0.614
Operative finding, MV prolapse
Anterior .03 1.200
Posterior .03 0.893
Both .07 0.762
TR, Tricuspid valve regurgitation; AF, atrial fibrillation; RA, right atrium; RV, right
ventricle; EF, ejection fraction; LVMI, left ventricular mass index; LAVI, left atrial
volume index; PAP, peak pulmonary arterial pressure; MV, mitral valve. *Change
in TR grade from preoperative values to those after>5 years of follow-up.
ery c September 2011
Yilmaz et al Acquired Cardiovascular Disease(P ¼ .02) were all independent predictors of increased TR
more than 5 years after MV repair. The presence of at least
moderate TR preoperatively was associated with a decrease
in TRwith time (P¼ .008). Pulmonary arterial pressurewas
not predictive of a change in TR during follow-up.Predictors of Mortality
There were 4 early deaths (0.6%), 2 (0.3%) of which
were within 30 days of surgery. Survivals at 5 and 10 years
after surgery were 93.9% and 76.1%, respectively. Multi-
variate analysis identified only older age (hazard ratio,
2.63; P<.001) as a predictor of decreased long-term sur-
vival (Table 3). The degree of preoperative TR was not
associated with early or late mortality.A
C
DDISCUSSION
We evaluated the clinical and echocardiographic out-
comes of a homogeneous population of patients with MV
prolapse and clinically silent functional TR undergoing iso-
lated MV repair and found that clinically important TR pro-
gression is unlikely to occur after repair of the MV in this
specific category of patients. Female sex, diabetes mellitus,
and a preoperative history of atrial fibrillation were all inde-
pendently associated with slight echocardiographic pro-
gression of TR over time; however, this was clinically
insignificant and did not lead to excess risk of reoperation.
Our data suggest that, in the absence of right heart failure,
surgical TV intervention for functional TR is rarely neces-
sary in patients undergoing isolated MV repair for degener-
ative leaflet prolapse.TABLE 3. Univariate and multivariate predictors of late mortality
Univariate Multivariate
Variable HR P value HR P value
Female sex .76
Age 1.09 <.001 2.63 <.001
Hypertension .37
Diabetes mellitus .19
Renal failure .54
COPD .007
Previous AF .22
Preoperative TR  grade 3 .02
RA dilatation .24
RV dilatation .28
EF 0.98 .19
LVEDD 0.93 .005
LVESD 0.97 .33
LAVI 1.01 .20
LVMI 1.01 .23
HR, Hazard ratio; COPD, chronic obstructive pulmonary disease; AF, atrial fibrilla-
tion; TR, tricuspid valve regurgitation; RA, right atrium; RV, right ventricle; EF, ejec-
tion fraction; LVEDD, left ventricular end-diastolic dimension; LVESD, left
ventricular end-systolic dimension; LAVI, left atrial volume index; LVMI, left ventric-
ular mass index.
The Journal of Thoracic and CaMV repair is the standard of care in patients with degen-
erativeMV disease.12 Patients who undergoMV repair have
normalization of life expectancy, have long-term freedom
from reoperation equivalent to that with mechanical valve
replacement, and avoid the need for valve-related anticoa-
gulation therapy.12 Recent data suggest that even in patients
with recurrent MR owing to primary repair failure, MV re-
repair is more efficacious than valve replacement in promot-
ing long-term regression of left ventricular dimensions and
improvement in patient survival.12
Coexistent TR is common in patients referred for surgery
for MV disease.13,14 Factors that have been shown to
increase the likelihood of TR progression include left ven-
tricular dysfunction, right ventricular dilatation or dysfun-
ction, pulmonary hypertension, and atrial fibrillation.15-17
Although early reports suggested that functional TR might
resolve spontaneously after MV replacement,1 it was subse-
quently discovered that some patients may have relentless
progression of TR leading to right heart failure necessitating
reoperation. This possibility is important because recurrent
severe TR has been shown to influence the long-term out-
come of patients treated for left heart pathologic pro-
cesses,15,18 and reoperation in this setting may be
associated with high early and late mortality.2-4,9 These
findings have led to a liberal approach to TV repair in
patients with TR who are undergoing MV surgery.2,4
Indeed, some clinicians have recommended repair of
coexistent TR on the basis of echocardiographic severity8
or tricuspid annular dimension.19
An important question is whether functional TR prog-
resses after correction of all types of left-sided valve dis-
ease. The difficulty with generalizing a response and
creating a unified approach to functional TR is that the un-
derlying MV disease processes are heterogeneous. Mecha-
nisms of left-sided valve disease are disparate and range
from rheumatic7 to ischemic and other cardiomyopathic
processes.10 Few data address coexistent TR in those
with the most frequent MV condition in the Western
world—degenerative MV leaflet prolapse. It is for this rea-
son that the current study was performed.
Our data demonstrate that the progression of TR in pa-
tients with isolated MV leaflet prolapse is unusual; the de-
gree of TR decreased within the first year overall and
increased only slightly after 5 years (Figure 2, A). Even at
5 years, however, the mean TR grade remained mild and,
as most would likely agree, clinically insignificant. It also
was surprising that TR grade for those in whom TR might
have been expected to increase (patients with at least mod-
erate preoperative TR) actually decreased significantly dur-
ing the first 3 years and remained lower than the
preoperative level overall (Figure 2, B). In patients with
less than moderate TR, however, TR was relatively stable
over time. Only 1 patient in our series had development
of severe symptomatic TR necessitating reoperation morerdiovascular Surgery c Volume 142, Number 3 611
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with rheumatic or ischemic MV disease, clinically signifi-
cant late TR has been shown to develop in 37% to
49%,3,10 and we agree with an aggressive approach to TV
repair in these patients.
Three factors were found to be independently associated
with an increase in TR with time in our series: female sex
(P ¼ .009), preoperative atrial fibrillation (P<.001), and
comorbid diabetes mellitus (P¼ .02) (Table 2). Previous re-
ports have identified atrial fibrillation, a large left atrium,
severe preoperative TR,8 older age,3,4 and female sex3 as
important predictors of late TR after left-sided cardiac sur-
gery. Although neither right nor left atrial size was associ-
ated with increased TR in the current analysis, atrial
fibrillation was predictive. In a recent study by Kwak and
associates17 examining the outcomes of 615 patients under-
going MV or MV and aortic valve surgery, preoperative
atrial fibrillation was also identified as the only important
predictor of late TR. Their study had important differences
from ours, such as their inclusion of patients with both ste-
notic and mixed MV lesions as well as those undergoing
aortic valve replacement. That study also found that patients
with severe TR had decreased long-term survival,17 which
differs from our own finding that survival is similarly high
regardless of follow-up TR grade. We suggest that the dis-
crepancies between these 2 reports are largely related to dif-
ferences in the populations analyzed. Finally, it is
interesting that pulmonary artery pressure was not an inde-
pendent predictor of TR progression in our series. It is
widely understood, however, that the etiology of functional
secondary TR is multifactorial and that some with pulmo-
nary hypertension may never have development of signifi-
cant TR.20
We found that moderate preoperative TR was a predictor
of decreased TR over time (P¼ .008) (Table 2) after correc-
tion of MR. This also differs from previously studied popu-
lations with varied MV pathologic processes, in which TR
higher than grade 2 was a risk factor for long-term TR pro-
gression.3,17 Whereas others have suggested that altered
right ventricular geometry and TV annular dilatation are
causative factors in the progression of late TR after MV
surgery for cardiomyopathy-related disease,21-23 it is
tempting to speculate that those with isolated MV leaflet
prolapse undergoing early valve repair may be less prone
to such changes because of the minimization of structural
remodeling of the interventricular myocardium. Given
that atrial fibrillation influences TR progression, the
concept of a myopathic influence on tricuspid annular size
and function is intriguing. Our group is currently testing
this hypothesis.
The study in the literature most similar to ours, published
by Dreyfus and associates19 in 2005, evaluated 311 patients
undergoing MV repair: 163 (52.4%) underwent MV repair
alone, and 148 (47.6%) additionally had TV repair because612 The Journal of Thoracic and Cardiovascular Surgof a tricuspid annular diameter of 70 mm or greater. They
found no difference between these groups in late survival,
cardiac-related events, or reoperation. However, TR pro-
gressed more frequently in those without TV intervention,
and New York Heart Association class was slightly worse
in this group. Several important differences exist between
that study and our own. First, whereas 100% of the patients
in our study had isolated MR owing to degenerative leaflet
prolapse, 35% of those in the study reported by Dreyfus and
associates19 had different MV disease related to ischemia,
rheumatic disease, endocarditis, or other cardiomyopathy.
It is widely understood that the natural history of these dis-
eases can be significantly discrepant; for example, there is
evidence to support progressive generalized valvulopathy
in rheumatic disease. In contrast, it is unclear why tricuspid
annular dilation in association with degenerative MV pro-
lapse, which alone is incapable of causing significant TR,
at the time of MV repair would cause subsequent develop-
ment of significant TR during follow-up. Finally, New York
Heart Association functional class is a poor measure of
right-sided heart failure symptoms related to significant un-
corrected functional TR.
It should again be noted that the current study examines
a homogeneous group of patients with severe degenerative
MR and some degree of coexistent TR to determine how the
TV in those with left-sided heart disease owing to MV leaf-
let prolapse might behave differently from that in patients
with mixed MV disease presented in prior reports. A recent
review by Rogers and Bolling24 reaffirms that the incidence
of TR after MV repair is dependent on the cause of MR.
Whereas Matsuyama and colleagues8 demonstrated that
only 16% of those undergoing MV repair for nonischemic
disease had moderate–severe TR at follow-up, Matsunaga
and Duran10 reported swift progression to greater than mod-
erate TR in 74% at more than 3 years of follow-up. It is
clear that the cause of left-sided heart disease influences
the incidence and progression of TR. Surgical decision-
making in the current era should reflect this important fact.
LIMITATIONS
This study is a retrospective review of prospectively col-
lected data and, as such, is influenced by typical biases. It
would have been ideal to compare the results of a similar
group of patients with isolated MV leaflet prolapse who un-
derwent concomitant TV intervention, but the small number
of such patients in our clinical experience (n ¼ 52) pre-
cludes a scientifically rigorous comparison. Although pa-
tients with MV prolapse who have a second related valve
disease (eg, significant secondary TR) are typically referred
for repeat echocardiography and clinical/surgical reassess-
ment at our institution, we acknowledge the possibility
that some within this population who had symptomatic re-
current TR may have sought care elsewhere and were thus
undetected by our routine follow-up. Furthermore, althoughery c September 2011
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right heart failure symptoms, our practice in general is to of-
fer surgery for symptomatic functional TR. Because of the
length of time over which this study was completed, there
are variations in the frequency and extent of echocardio-
graphic follow-up. Finally, the technical ability to reproduc-
ibly quantify TR also improved over the course of the study
as echocardiographic technology evolved.
CONCLUSIONS
Asymptomatic nonsevere functional TR found in associ-
ation with severe MR caused by MV leaflet prolapse may
not require surgical correction at the time of MV repair. Al-
though the cost of TVinterventionmay at times be low, a co-
gent evidence-based surgical strategy is warranted in this
group of patients. A thoughtful approach to the TV should
consider preoperative risk factors such as atrial fibrillation,
sex, and diabetes mellitus. Further study is necessary to un-
derstand the complex relationship between left- and right-
sided heart disease in this important patient population.
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MR
Grade  3* Total Grade  3*
115 (16.5) 699 699 (100)
110 (17.5) 679 26 (3.8)
38 (15.2) 278 16 (5.8)
42 (20.3) 219 18 (8.2)
33 (22.8) 151 12 (7.9)
32 (29.4) 110 11 (10)
nts (%).
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